CEO Geoff Tanner opened by expressing confidence in the company’s plan and reaffirmed the full year outlook for net sales and adjusted EBITDA. Tanner highlighted, “Consumption in Q1 grew 2%, led by ...

Forget about Herceptin. There’s a new HER2 agent that ought to be used in HER2-positive stomach cancer, and that’s Jazz ...

Urinary incontinence (UI) and overactive bladder (OAB) are more common adverse health outcomes in patients who have ...

From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...

Manuel Pellegrini did not attempt to soften the blow after Real Betis’ heavy 5–1 defeat to Real Madrid at the Santiago ...

Communication Services Select Sector SPDR ETF (XLC) offers the most attractive blend of value and growth for 2026, with a 38% ...

With more cutting to do, it makes sense to add exposure by swapping to floating. A 'Maga dovish' Fed would takes us to ...

A comprehensive review confirms the benefits of exercise for treating depression, even if the exact reasons remain unclear ...

After beating Georgia at home to get square at 1-1 in SEC play the Florida Gators will now welcome to Gainesville one of the ...

Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in ...

Longer-term results from the BENEFIT trial show sustained minimal residual disease negativity in newly diagnosed, ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical ...